These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12651814)

  • 1. Standardization of immunoassays for measurement of high-sensitivity C-reactive protein. Phase I: evaluation of secondary reference materials.
    Kimberly MM; Vesper HW; Caudill SP; Cooper GR; Rifai N; Dati F; Myers GL
    Clin Chem; 2003 Apr; 49(4):611-6. PubMed ID: 12651814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and preparation of a new serum protein reference material: feasibility studies and processing.
    Zegers I; Schreiber W; Linstead S; Lammers M; McCusker M; Muñoz A; Itoh Y; Merlini G; Trapmann S; Emons H; Sheldon J; Schimmel H
    Clin Chem Lab Med; 2010 Jun; 48(6):805-13. PubMed ID: 20374041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization of immunoassays for measurement of myoglobin in serum. Phase I: evaluation of candidate secondary reference materials.
    Panteghini M; Linsinger T; Wu AH; Dati F; Apple FS; Christenson RH; Mair J; Schimmel H
    Clin Chim Acta; 2004 Mar; 341(1-2):65-72. PubMed ID: 14967160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical performance and clinical efficacy for cardiovascular risk estimation of an Olympus immunoturbidimetric high-sensitivity C-reactive protein assay.
    Jovicić S; Ignjatović S; Dajak M; Majkić-Singh N
    Clin Chem Lab Med; 2006; 44(2):228-31. PubMed ID: 16475913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardization of high-sensitivity immunoassays for measurement of C-reactive protein; II: Two approaches for assessing commutability of a reference material.
    Kimberly MM; Caudill SP; Vesper HW; Monsell EA; Miller WG; Rej R; Rifai N; Dati F; Myers GL
    Clin Chem; 2009 Feb; 55(2):342-50. PubMed ID: 19074518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical performance of the Synchron LX20 Pro, BN trade mark II and IMMAGE high sensitivity C-reactive protein assays and concordance in cardiovascular risk stratification.
    McWhorter VC; Ford LC; Butch AW
    Clin Chim Acta; 2004 Sep; 347(1-2):71-9. PubMed ID: 15313143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internal quality control of a turbidimetric immunoassay for canine serum C-reactive protein based on pooled patient samples.
    Kjelgaard-Hansen M; Jensen AL; Kristensen AT
    Vet Clin Pathol; 2004; 33(3):139-44. PubMed ID: 15334348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: laboratory tests available to assess inflammation--performance and standardization: a background paper.
    Roberts WL; ;
    Circulation; 2004 Dec; 110(25):e572-6. PubMed ID: 15611384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commutability of the CRM 470 C-reactive protein value in the Dade Behring N High Sensitivity CRP assay.
    Johnson AM; Ledue TB; Collins MF
    Clin Chem Lab Med; 2003 Feb; 41(2):177-82. PubMed ID: 12667004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum protein standardization project in Japan: evaluation of an IFCC reference material (RPPHS/CRM470) and establishment of reference intervals.
    Itoh Y; Ichihara K; Kanno T; Sugawara T; Ohkubo A; Hirabayashi Y; Igarashi S; Kawano K; Iwata S; Saito K; Kawai T
    J Clin Lab Anal; 1997; 11(1):39-44. PubMed ID: 9021523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of C-reactive protein: two high sensitivity methods compared.
    Dominici R; Luraschi P; Franzini C
    J Clin Lab Anal; 2004; 18(5):280-4. PubMed ID: 15356879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of C-reactive protein certified reference material NMIJ CRM 6201-b: optimization of a hydrolysis process to improve the accuracy of amino acid analysis.
    Kato M; Kinumi T; Yoshioka M; Goto M; Fujii S; Takatsu A
    Anal Bioanal Chem; 2015 Apr; 407(11):3137-46. PubMed ID: 25303928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a species-specific C-reactive protein assay for the dog on the ABX Pentra 400 clinical chemistry analyzer.
    Hindenberg S; Klenner-Gastreich S; Kneier N; Zielinsky S; Gommeren K; Bauer N; Moritz A
    BMC Vet Res; 2017 May; 13(1):146. PubMed ID: 28558755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2.
    Roberts WL; Moulton L; Law TC; Farrow G; Cooper-Anderson M; Savory J; Rifai N
    Clin Chem; 2001 Mar; 47(3):418-25. PubMed ID: 11238291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoturbidimetric determination of C-reactive protein (CRP) and high-sensitivity CRP on heparin plasma. Comparison with serum determination.
    Dupuy AM; Badiou S; Descomps B; Cristol JP
    Clin Chem Lab Med; 2003 Jul; 41(7):948-9. PubMed ID: 12940523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a fully-automated particle-enhanced turbidimetric immunoassay for the measurement of plasma lipoprotein(a). population-based reference values in an area with low incidence of cardiovascular disease.
    Simó JM; Camps J; Gómez F; Ferré N; Joven J
    Clin Biochem; 2003 Mar; 36(2):129-34. PubMed ID: 12633762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison and evaluation of two C-reactive protein assays based on particle-enhanced immunoturbidimetry.
    Sişman AR; Küme T; Taş G; Akan P; Tuncel P
    J Clin Lab Anal; 2007; 21(2):71-6. PubMed ID: 17385663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of three automated human immunoturbidimetric assays for the detection of C-reactive protein in dogs.
    Klenner S; Bauer N; Moritz A
    J Vet Diagn Invest; 2010 Jul; 22(4):544-52. PubMed ID: 20622224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment.
    Ledue TB; Rifai N
    Clin Chem; 2003 Aug; 49(8):1258-71. PubMed ID: 12881440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 3 automated assays for C-reactive protein in end-stage renal disease: clinical and epidemiological implications.
    Maggiore U; Cristol JP; Canaud B; Dupuy AM; Formica M; Pozzato M; Panichi V; Consani C; Metelli MR; Sereni L; De Nitti C; David S; Tetta C
    J Lab Clin Med; 2005 Jun; 145(6):305-8. PubMed ID: 15976758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.